Transcriptomic profiling and targeted validation reveal molecular mechanisms of oxygen therapy in high-altitude cerebral injury.

Although the HBO group exhibited numerically lower injury scores than the NBO group, the difference between these two treatments did not reach statistical significance ( p > 0.05).

also in 111,027 other papers